West Paces Advisors’s Agios Pharmaceuticals AGIO Stock Holding History

West Paces Advisors’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-255	Closed	-$11.8K	–	473
2018 Q4	$11.8K	Hold	255	–	–	0.01%	300
2018 Q3	$19.7K	Hold	255	–	–	0.01%	253
2018 Q2	$21.5K	Hold	255	–	–	0.02%	250
2018 Q1	$20.9K	Hold	255	–	–	0.02%	236
2017 Q4	$14.6K	Hold	255	–	–	0.01%	296
2017 Q3	$17K	Hold	255	–	–	0.01%	276
2017 Q2	$13.1K	Hold	255	–	–	0.01%	300
2017 Q1	$14.9K	Buy	+255	New	+$12.2K	0.01%	281

Other funds holding AGIO

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

WIM

Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

West Paces Advisors's AGIO Position: Q1 2019 in Review

West Paces Advisors sold out of Agios Pharmaceuticals (AGIO) in Q1 2019, closing a stake of 255 shares — an estimated $11.8K sold.

West Paces Advisors first reported a position in AGIO in Q1 2017 and held it in 8 quarters. The position peaked at $21.5K in Q2 2018. 201 funds tracked by Wall St. Rank hold AGIO as of Q1 2019.

West Paces Advisors reported no remaining Agios Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
West Paces Advisors sold 255 Agios Pharmaceuticals shares in Q1 2019, an estimated $11.8K.
West Paces Advisors first reported a position in Agios Pharmaceuticals in Q1 2017 and held it in 8 quarters.
West Paces Advisors's Agios Pharmaceuticals position peaked at $21.5K in Q2 2018.
201 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2019.

Based on West Paces Advisors's 13F filing for Q1 2019, filed 22 Dec 2023.